CYP4B1 was regarded as a prognostic biomarker and tumor suppressor for lung cancer (LC) [49], and missense variants in CYP4B1 were correlated with LC susceptibility [50]. Here, CYP4B1 is linked to laryngotracheoesophageal cleft.